Contemporary Therapy e-Monograph

Contemporary Therapy for HL: Where Are We Now?
Contemporary Therapy for HL: Where Are We Now?
CME, CPE, CNE
Franco Cavalli, MD, FRCP; Tim Illidge, PhD, MRCP, FRCR, FRCPath; Peter Borchmann, MD
Release Date: October 16, 2015
Expiration Date: October 16, 2016

This activity has been designed to offer you the latest therapeutic insights for the management of Hodgkin lymphoma (HL) from current practice to the status of ongoing clinical trials.

Provided by MediCom Worldwide, Inc.
This activity has been supported by educational grants from Takeda Oncology and Seattle Genetics, Inc. MediCom Worldwide, Inc. acknowledges support from The Leukemia & Lymphoma Society
View Only, CE ExpiredView Only, No Credit
 

Managing HL would like to recognize and thank Merck & Co., Inc., Seattle Genetics, and Takeda Oncology for their educational support of ManagingHodgkinLymphoma.com

©2017 MediCom Worldwide, Inc. All rights reserved